Large B cell lymphoma presenting initially in bone marrow, liver and spleen: An aggressive entity associated frequently with haemophagocytic syndrome

Histopathology

Volumn 57, Issue 6, 2010, Pages 785-795

  Yeh, Yu Min ^a   Chang, Kung Chao ^a   Chen, Ya Ping ^a   Kao, Lin Yuan ^a   Tsai, Huey Pin ^a   Ho, Chung Liang ^a   Wang, Jen Ren ^a,b   Jones, Dan ^c   Chen, Tsai Yun ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Aggressive behaviour; Bone marrow; Clinicopathological features; Cytogenetics; Diffuse large B cell lymphoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; LARGE CELL LYMPHOMA; LIVER; MALE; PRIORITY JOURNAL; SPLEEN; TREATMENT OUTCOME; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CYTOGENETICS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; LIVER; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6;

EID: 78650247363     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03709.x     Document Type: Article

References (33)

1. Swerdlow SH, Campo E, Harris NL et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 2008.
2. Chang KC, Huang GC, Jones D et al. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leuk. Lymph. 2004; 45; 1375-1384.
3. Oyama T, Ichimura K, Suzuki R et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am. J. Surg. Pathol. 2003; 27; 16-26.
4. Alvares CL, Matutes E, Scully MA et al. Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk. Lymph. 2004; 45; 769-775.
5. Kajiura D, Yamashita Y, Mori N. Diffuse large B-cell lymphoma initially manifesting in the bone marrow. Am. J. Clin. Pathol. 2007; 127; 762-769.
6. Mollejo M, Algara P, Mateo MS et al. Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am. J. Surg. Pathol. 2003; 27; 895-902.
7. Morice WG, Rodriguez FJ, Hoyer JD, Kurtin PJ. Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases. Mod. Pathol. 2005; 18; 495-502.
8. Strauchen JA. Primary bone marrow B-cell lymphoma: report of four cases. Mt Sinai J. Med. 2003; 70; 133-138.
9. Wong KF, Chan JK, Ng CS et al. Large cell lymphoma with initial presentation in the bone marrow. Hematol. Oncol. 1992; 10; 261-271.
10. Allory Y, Challine D, Haioun C et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. Am. J. Surg. Pathol. 2001; 25; 865-874.
11. Chang KC, Huang GC, Jones D, Lin YH. Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses. Clin. Cancer Res. 2007; 13; 6666-6672.
12. Huang WT, Chang KC, Huang GC et al. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type. Haematologica 2005; 90; 1063-1069.
13. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103; 275-282.
14. Chang KC, Khen NT, Jones D, Su IJ. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum. Pathol. 2005; 36; 747-755.
15. Huang LM, Kuo PF, Lee CY et al. Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma. J. Med. Virol. 1992; 38; 7-10.
16. Su IJ, Hsu YS, Chang YC, Wang IW. Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan. Lancet 1995; 345; 722-723.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53; 457-481.
18. Gehan EA. A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 1965; 52; 650-653.
19. Henter JI, Horne A, Arico M et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2007; 48; 124-131.
20. Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. J. Clin. Oncol. 2005; 23; 6351-6357.
21. Campbell LJ. Cytogenetics of lymphomas. Pathology 2005; 37; 493-507.
22. Younes A, Jendiroba D, Engel H et al. High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement. Cancer Genet. Cytogenet. 1994; 77; 39-44.
23. Murase T, Nakamura S, Kawauchi K et al. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br. J. Haematol. 2000; 111; 826-834.
24. Chuang HC, Lay JD, Chuang SE et al. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. Am. J. Pathol. 2007; 170; 1607-1617.
25. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J. Clin. Invest. 1997; 100; 1969-1979.
26. Anderson LA, Pfeiffer R, Warren JL et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol. Biomarkers Prev. 2008; 17; 3069-3075.
27. Chen MH, Hsiao LT, Chiou TJ et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann. Hematol. 2008; 87; 475-480.
28. Ishida T, Inagaki H, Kusumoto S et al. CC chemokine receptor 4-positive diffuse large B-cell lymphoma involving the skin: a case report. Int. J. Hematol. 2005; 82; 148-151.
29. Smith JR, Braziel RM, Paoletti S et al. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 2003; 101; 815-821.
30. Kashimura M, Noro M, Akikusa B et al. Primary splenic diffuse large B-cell lymphoma manifesting in red pulp. Virchows Arch. 2008; 453; 501-509.
31. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Tumors of the Lymph Nodes and Spleen. Washington, DC: AFIP, 1995.
32. Kawauchi K, Ogasawara T, Yasuyama M. [Clinical characterization of B cell lymphoma-associated hemophagocytic syndrome]. Nihon Rinsho Meneki Gakkai Kaishi 2000; 23; 454-461.
33. Murase T, Nakamura S. An Asian variant of intravascular lymphomatosis: an updated review of malignant histiocytosis-like B-cell lymphoma. Leuk. Lymph. 1999; 33; 459-473.